Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 10/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.36 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.36 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.36 |
| ▸ | NPY1R | P25929 | 5/20 | 0.36 |
| ▸ | NPY2R | P49146 | 5/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.36 |
| ▸ | IL23R | Q5VWK5 | 5/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | TFPI | P10646 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9614819 | 0.95 | NPY4R (0.37) | NPY4RKEAP1NPY1RNPY2RNPY5R | |
| Trifluoroacetic Acid SCHEMBL7437664 | 0.84 | NPY4R (0.44) | NPY4RKEAP1ITGB1ITGA4NPY1R | |
| Trifluoroacetic Acid SCHEMBL9614803 | 0.83 | NPY4R (0.48) | NPY4RITGB1ITGA4NPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL9614815 | 0.82 | NPY4R (0.49) | NPY4RITGB1ITGA4NPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL9614791 | 0.82 | NPY4R (0.49) | NPY4RITGB1ITGA4NPY1RNPY2R | |
| Trifluoroacetic Acid SCHEMBL9614806 | 0.82 | NPY4R (0.49) | NPY4RITGB1ITGA4NPY1RNPY2R | |
| SCHEMBL29598552 | 0.81 | NPY4R (0.41) | NPY4RKEAP1NPY1RNPY2RNPY5R | |
| Trifluoroacetic Acid SCHEMBL9614816 | 0.81 | NPY4R (0.39) | NPY4RKEAP1ITGB1ITGA4NPY1R | |
| Trifluoroacetic Acid SCHEMBL9614798 | 0.80 | EPHX2 (0.41) | NPY4RITGB1ITGA4 | |
| SCHEMBL29536042 | 0.80 | GNPAT (0.44) | NPY4RKEAP1NPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494248-A4 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | — | 1992-08-26 | — | — | EP | disclosed |
| EP-0494248-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-07-15 | — | — | EP | disclosed |
| WO-1991004746-A1 | ANTI-THROMBOTIC PEPTIDES AND PSEUDOPEPTIDES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| US-4952562-A | TREATMENT OF CARDIOVASCULAR DISORDERS | RORER PHARMACEUTICAL CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |